Nodal negatively regulates osteoclast differentiation by inducing STAT1 phosphorylation. 2024

Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
Department of Pharmacology, Chonnam National University Medical School, Gwangju, South Korea.

Several members of the transforming growth factor beta (TGF-β) superfamily regulate the proliferation, differentiation, and function of bone-forming osteoblasts and bone-resorbing osteoclasts. However, it is still unknown whether Nodal, a member of the TGF-β superfamily, serves a function in bone cells. In this study, we found that Nodal did not have any function in osteoblasts but instead negatively regulated osteoclast differentiation. Nodal inhibited RANKL-induced osteoclast differentiation by downregulating the expression of pro-osteoclastogenic genes, including c-fos, Nfatc1, and Blimp1, and upregulating the expression of antiosteoclastogenic genes, including Bcl6 and Irf8. Nodal activated STAT1 in osteoclast precursor cells, and STAT1 downregulation significantly reduced the inhibitory effect of Nodal on osteoclast differentiation. These findings indicate that Nodal activates STAT1 to downregulate or upregulate the expression of pro-osteoclastogenic or antiosteoclastogenic genes, respectively, leading to the inhibition of osteoclast differentiation. Moreover, the inhibitory effect of Nodal on osteoclast differentiation contributed to the reduction of RANKL-induced bone loss in vivo.

UI MeSH Term Description Entries

Related Publications

Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
April 2012, Journal of cellular biochemistry,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
August 2023, Free radical biology & medicine,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
November 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
June 2010, Molecular biology of the cell,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
June 2013, Oncology reports,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
December 2020, Biochemical and biophysical research communications,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
November 2015, Cell reports,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
February 2022, Science China. Life sciences,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
May 2016, Nature medicine,
Jung Ha Kim, and Kabsun Kim, and Inyoung Kim, and Semun Seong, and Jeong-Tae Koh, and Nacksung Kim
April 2022, JBMR plus,
Copied contents to your clipboard!